DEA Schedule CIII
Strength
12; 3 mg/1; mg/1
Manufacturer
Indivior Inc.NDC
12496121203
Classification
Brand
Dosage Form
FILM, SOLUBLE
Route
BUCCAL; SUBLINGUAL
Last Updated
4/22/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022410On Market Since
8/24/2012
Pharmacological Classes
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
CONTRAVE ER 8-90 MG TABLET
Brand
51267089099•Nalpropion Pharmaceuticals LLC
$4.9810
per EA
ZUBSOLV 0.7-0.18 MG TABLET SL
Brand
54123090730•Orexo US, Inc.
$5.2599
per EA
ZUBSOLV 1.4-0.36 MG TABLET SL
Brand
54123091430•Orexo US, Inc.
$5.2767
per EA
BELBUCA 150 MCG FILM
Brand
59385002260•BioDelivery Sciences International Inc
$7.5560
per EA
BELBUCA 75 MCG FILM
Brand
59385002160•BioDelivery Sciences International Inc
$7.5635
per EA
ZUBSOLV 2.9-0.71 MG TABLET SL
Brand
54123092930•Orexo US, Inc.
$10.5396
per EA
ZUBSOLV 5.7-1.4 MG TABLET SL
Brand
54123095730•Orexo US, Inc.
$10.5559
per EA
BELBUCA 300 MCG FILM
Brand
59385002360•BioDelivery Sciences International Inc
$11.8705
per EA
MOVANTIK 12.5 MG TABLET
Brand
82625880101•Valinor Pharma, LLC
$14.6029
per EA
MOVANTIK 25 MG TABLET
Brand
57841130101•RedHill Biopharma Ltd
$14.6309
per EA